[en] We examined whether an increase in high-sensitivity C-reactive protein (hs-CRP) after percutaneous coronary intervention (PCI) predicts long-term prognosis in patients with stable angina pectoris. hs-CRP is an inflammatory marker that predicts future cardiovascular events in healthy subjects and patients with unstable and stable coronary syndromes. Long-term evaluation of pre- and postprocedural inflammatory markers has not been widely reported. In particular, the effect of the magnitude of increase in hs-CRP after PCI in stable patients is unknown. We prospectively analyzed 89 stable patients treated by PCI for stable angina pectoris. Patients were recruited between August 1998 and May 1999, and the population was followed until August 2005 (mean follow-up 79.5 +/- 10.3 months). A major adverse cardiac event (MACE) was defined as the occurrence of cardiac death, myocardial infarction, or recurrent angina requiring repeat PCI or coronary artery bypass grafting. During the follow-up period, 36 patients presented with > or =1 MACE. In multivariate analysis, independent predictors of the occurrence of MACEs were previous myocardial infarction and a significant increase in hs-CRP after PCI (p = 0.004 and 0.003, respectively). A significant increase in hs-CRP after PCI was found to be more predictive of MACEs than hs-CRP before and after PCI. In conclusion, in stable coronary artery disease, inflammation is associated with long-term adverse events, but the magnitude of the inflammatory reaction after PCI appears more predictive than the baseline value.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
Gach, Olivier ; Centre Hospitalier Universitaire de Liège - CHU > Cardiologie
Legrand, Victor ; Université de Liège - ULiège > Département des sciences cliniques > Cardiologie
Biessaux, Yves ; Centre Hospitalier Universitaire de Liège - CHU > Cardiologie
Chapelle, Jean-Paul ; Université de Liège - ULiège > Département de pharmacie > Chimie médicale
Vanbelle, Sophie ; Université de Liège - ULiège > Département des sciences de la santé publique > Informatique médicale et biostatistique
Pierard, Luc ; Université de Liège - ULiège > Cardiologie
Language :
English
Title :
Long-term prognostic significance of high-sensitivity C-reactive protein before and after coronary angioplasty in patients with stable angina pectoris
Ridker P.M., Rifai N., Rose L., Buring J.E., and Cook N.R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347 (2002) 1557-1565
Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 (2000) 836-843
Zebrack J.S., Muhlestein J.B., Horne B.D., and Anderson J.L. C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina. J Am Coll Cardiol 39 (2002) 632-637
Azar R.R., McKay R.G., Kiernan F.J., Seecharran B., Feng Y.J., Fram D.B., Wu A.H., and Waters D.D. Coronary angioplasty induces a systemic inflammatory response. Am J Cardiol 80 (1997) 1476-1478
Saadeddin S.H., Habbab M.A., Sobki S.H., and Ferns G.A. Association of systemic inflammatory state with troponin I elevation after elective uncomplicated percutaneous coronary intervention. Am J Cardiol 89 (2002) 981-983
Chew D.P., Bhatt D.L., Robbins M.A., Penn M.S., Schneider J.P., Lauer M.S., Topol E.J., and Ellis S.G. Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention. Circulation 104 (2001) 992-997
De Winter R.J., Heyde G.S., Koch K.T., Fischer J., van Straalen J.P., Bax M., Schotborgh C.E., Mulder K.J., Sanders G.T., Piek J.J., and Tijssen J.G. The prognostic value of pre-procedural plasma C-reactive protein in patients undergoing elective coronary angioplasty. Eur Heart J 23 (2002) 960-966
Dibra A., Mehilli J., Braun S., Hadamitzky M., Baum H., Dirschinger J., Schuhlen H., Schomig A., and Kastrati A. Association between C-reactive protein levels and subsequent cardiac events among patients with stable angina treated with coronary artery stenting. Am J Med 114 (2003) 715-722